Evidence map›Paper›PMID 40749025›Full record

ArticlePLOS global public health2025

A peer-educator driven approach for sampling populations at increased mpox risk in the Democratic Republic of the Congo: Implications for surveillance and response.

Sydney Merritt, Megan Halbrook, Yvon Anta, Patrick K Mukadi, Emmanuel Hasivirwe Vakaniaki, Tavia Bodisa-Matamu, Lygie Lunyanga, Cris Kacita, Jean Paul Kompany, Jean-Claude Makangara-Cigolo and 16 more

Abstract read
In one paragraph

Article in PLOS global public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Sydney MerrittJonathan and Karin Fielding School of Public Health, Department of Epidemiology, University of California, Los Angeles, California, United States of America.ORCID https://orcid.org/0000-0002-4039-605X
Megan HalbrookJonathan and Karin Fielding School of Public Health, Department of Epidemiology, University of California, Los Angeles, California, United States of America.ORCID https://orcid.org/0000-0002-3892-2655
Yvon AntaDepartment of Epidemiology and Global Health, Institut National de Recherche Biomedical (INRB), Kinshasa, Kinshasa, Democratic Republic of the Congo.
Patrick K MukadiDepartment of Epidemiology and Global Health, Institut National de Recherche Biomedical (INRB), Kinshasa, Kinshasa, Democratic Republic of the Congo.ORCID https://orcid.org/0000-0001-9312-9345
Emmanuel Hasivirwe VakaniakiDepartment of Epidemiology and Global Health, Institut National de Recherche Biomedical (INRB), Kinshasa, Kinshasa, Democratic Republic of the Congo.
Tavia Bodisa-MatamuRodolphe Mérieux Institut National de Recherche Biomedicale Laboratory, Goma, North Kivu, Democratic Republic of the Congo.
Lygie LunyangaDepartment of Epidemiology and Global Health, Institut National de Recherche Biomedical (INRB), Kinshasa, Kinshasa, Democratic Republic of the Congo.ORCID https://orcid.org/0009-0006-0127-1250
Cris KacitaNational Program for Monkeypox and Viral Hemorrhagic Fevers, Ministry of Health, Kinshasa, Kinshasa, Democratic Republic of the Congo.
Jean Paul KompanyDepartment of Epidemiology and Global Health, Institut National de Recherche Biomedical (INRB), Kinshasa, Kinshasa, Democratic Republic of the Congo.
Jean-Claude Makangara-CigoloDepartment of Epidemiology and Global Health, Institut National de Recherche Biomedical (INRB), Kinshasa, Kinshasa, Democratic Republic of the Congo.ORCID https://orcid.org/0000-0002-1791-2247
Michel KenyeDepartment of Epidemiology and Global Health, Institut National de Recherche Biomedical (INRB), Kinshasa, Kinshasa, Democratic Republic of the Congo.
Sifa KaviraDepartment of Epidemiology and Global Health, Institut National de Recherche Biomedical (INRB), Kinshasa, Kinshasa, Democratic Republic of the Congo.
Thierry KalonjiNational Program for Monkeypox and Viral Hemorrhagic Fevers, Ministry of Health, Kinshasa, Kinshasa, Democratic Republic of the Congo.
Sylvie LinsukeDepartment of Epidemiology and Global Health, Institut National de Recherche Biomedical (INRB), Kinshasa, Kinshasa, Democratic Republic of the Congo.ORCID https://orcid.org/0000-0003-4283-0435
Emile MalembiNational Program for Monkeypox and Viral Hemorrhagic Fevers, Ministry of Health, Kinshasa, Kinshasa, Democratic Republic of the Congo.
Daniel Mukadi-BamulekaService de Microbiologie, Département de Biologie Médicale, Cliniques Universitaires de Kinshasa, Université de Kinshasa, Kinshasa, Democratic Republic of the Congo.
Liliane SabiDepartment of Epidemiology and Global Health, Institut National de Recherche Biomedical (INRB), Kinshasa, Kinshasa, Democratic Republic of the Congo.
Candice LemailleMax Rady College of Medicine, Department of Medical Microbiology & Infectious Diseases, University of Manitoba, Winnipeg, Manitoba, Canada.
Marie Clotilde InakaNational Program for HIV/AIDS, Ministry of Health, Kinshasa, Kinshasa, Democratic Republic of the Congo.
Nicola LowInstitute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.ORCID https://orcid.org/0000-0003-4817-8986
Lisa E HensleyZoonotic and Emerging Disease Research Unit, National Bio and Agro-Defense Facility, Agricultural Research Service (ARS), United States Department of Agriculture (USDA), Manhattan, Kansas, United States of America.
Nicole A HoffJonathan and Karin Fielding School of Public Health, Department of Epidemiology, University of California, Los Angeles, California, United States of America.
Robert ShongoNational Program for Monkeypox and Viral Hemorrhagic Fevers, Ministry of Health, Kinshasa, Kinshasa, Democratic Republic of the Congo.
Jason KindrachukMax Rady College of Medicine, Department of Medical Microbiology & Infectious Diseases, University of Manitoba, Winnipeg, Manitoba, Canada.
Anne W RimoinJonathan and Karin Fielding School of Public Health, Department of Epidemiology, University of California, Los Angeles, California, United States of America.ORCID https://orcid.org/0000-0002-0662-9067
Placide Mbala-KingebeniDepartment of Epidemiology and Global Health, Institut National de Recherche Biomedical (INRB), Kinshasa, Kinshasa, Democratic Republic of the Congo.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The epidemiological risk factors associated with mpox acquisition and severity in the Democratic Republic of the Congo (DRC) are changing. We assessed perceived mpox risk, and behavioral, clinical and sexual histories among key populations at risk of acquisition through sexual contact. Here, we describe a sampling strategy to enroll participants considered to be at increased risk for mpox infection - men who have sex with men (MSM) and sex workers (SW) - in three urban centers in the DRC. Through the combined approach of time-location sampling with peer educators and respondent-driven sampling, a mixed cohort of 2826 individuals including self-identified MSM (n = 850), SW (n = 815), both MSM and SW (n = 118) and non-MSM, non-SW individuals (n = 1043) were enrolled in Kinshasa, Kinshasa province, Kenge, Kwango province, and Goma, North Kivu province, from March-August 2024. Of these, over 90% were reached through peer educators. The odds of sampling SW individuals were higher at bars/clubs than traditional health facilities. Conversely, the odds of enrolling MSM were highest at selected health facilities. Modifications to the sampling approach were introduced in Kenge and Goma, but these did not affect the enrollment of MSM or SW participants. Ultimately, the selection of, and collaboration with, well-integrated peer educators was the most important facet of this sampling strategy. As the definitions of at-risk populations continue to change for mpox, we demonstrate a functional approach to quickly surveying otherwise hard-to-reach groups for both public health surveillance activities and response.

Identifiers

PMID40749025
PMCPMC12316315

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.